In the present study, we assessed the microglial activity marker Gal-3 in clinically diagnosed and neuropathologically confirmed AD patients and analyzed the relationship between CSF levels of Gal-3 and AD markers and characteristics in a clinical cohort. The gene discussed is LGALS3; the disease is Alzheimer disease.